Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000443 · ClinicalTrials.gov registry record · Phase 2

Ondansetron Treatment for Alcoholism

A Phase 2 study of Alcoholism, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Completed
Registry status
Phase 2
Development phase
1
Study location

NCT00000443: Completed Phase 2 study of Alcoholism, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

NCT00000443 is a Phase 2 study of Alcoholism that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000443, a Phase 2 study of Alcoholism, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

COMPLETED
Registry status
Phase 2
Development phase
1
Study location

Study Summary

The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to treatment. Individuals will be "typed" into early onset and late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient treatment program.

Conditions Studied

Alcoholism

Interventions

  • DRUG ondansetron (Zofran)

Study Locations (1)

Texas

  • Substance Abuse Research Center, University of Texas Health Science Center - Houston

Trial Details

FieldValue
Est. Completion 2000-04
Phase Phase 2
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

93 total trials

What the finished NCT00000443 record still lists

NCT00000443 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 1 condition, with Alcoholism appearing as the primary indexed condition, and to 1 intervention - of which ondansetron (Zofran) is the first listed.

NCT00000443 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00000443 about?

NCT00000443 is a clinical study titled "Ondansetron Treatment for Alcoholism". The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to...

What is the current status of trial NCT00000443?

This trial is currently completed. It is a Phase 2 study. Estimated completion is 2000-04.

What conditions does trial NCT00000443 study?

This clinical trial studies the following conditions: Alcoholism.

What interventions are being tested in trial NCT00000443?

The interventions under investigation include: ondansetron (Zofran) (DRUG).

Who is sponsoring clinical trial NCT00000443?

This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000443 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcoholism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Related registry views

Source: ClinicalTrials.gov NCT00000443, the US trial registry maintained by the National Library of Medicine. NCT00000443 (unsized enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.